Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: A validation study

Journal of Cerebral Blood Flow and Metabolism

Volumn 35, Issue 9, 2015, Pages 1478-1484

  Meles, Sanne K ^a   Tang, Chris C ^b   Teune, Laura K ^a   Dierckx, Rudi A ^a   Dhawan, Vijay ^b   Mattis, Paul J ^b   Leenders, Klaus L ^a   Eidelberg, David ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

brain network; cognitive impairment; FDG PET; metabolic pattern; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE DURATION; EXECUTIVE FUNCTION; FEMALE; FRONTAL ASSESSMENT BATTERY; HUMAN; IMAGE PROCESSING; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NERVE CELL NETWORK; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PARKINSON DISEASE COGNITION RELATED PATTERN; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TOPOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDATION STUDY; CLINICAL TRIAL; METABOLISM; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84940722441     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.112     Document Type: Article

References (44)

1. Ziemssen T, Reichmann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2007; 13: 323-332.
2. Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999; 14: 866-874.
3. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000; 48: 938-942.
4. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 69: 308-312.
5. Muslimovic D, Post B, Speelman JD, De Haan RJ, Schmand B. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc 2009; 15: 426-437.
6. Aarsland D, Bronnick K, Fladby T. Mild cognitive impairment in Parkinson's disease. Curr Neurol Neurosci Rep 2011; 11: 371-378.
7. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
8. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci 2009; 32: 548-557.
9. Niethammer M, Eidelberg D. Metabolic brain networks in translational neurology: concepts and applications. Ann Neurol 2012; 72: 635-647.
10. Tang CC, Niethammer M, Allen PJ, Leenders KL, Eidelberg D. PET and SPECT imaging in Parkinsonian syndromes. In: Dierckx RA, Otte A, de Vries EFJ, van Waarde A, Leenders KL (eds). PET and SPECT in Neurology. Springer-Verlag: Berlin, Heidelberg, Germany, 2014, pp 619.
11. Teune LK, Renken RJ, Mudali D, De Jong BM, Dierckx RA, Roerdink JB et al. Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord 2013; 28: 547-551.
12. Spetsieris P, Ma Y, Peng S, Ko JH, Dhawan V, Tang CC et al. Identification of disease-related spatial covariance patterns using neuroimaging data. J Vis Exp 2013; 76: e50319.
13. Spetsieris PG, Eidelberg D. Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Neuroimage 2011; 54: 2899-2914.
14. Ma Y, Tang C, Spetsieris P, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 2007; 27: 597-605.
15. Mure H, Hirano S, Tang CC, Isaias IU, Antonini A, Ma Y et al. Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage 2011; 54: 1244-1253.
16. Teune LK, Renken RJ, de Jong BM, Willemsen AT, van Osch MJ, Roerdink JB et al. Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging. Neuroimage Clin 2014; 5: 240-244.
17. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 2007; 34: 714-723.
18. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007; 130: 1834-1846.
19. Mattis PJ, Tang CC, Ma Y, Dhawan V, Eidelberg D. Network correlates of the cognitive response to levodopa in Parkinson disease. Neurology 2011; 77: 858-865.
20. Tang C, Poston K, Dhawan V, Eidelberg D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci 2010; 30: 1049-1056.
21. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 2008; 70: 1470-1477.
22. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621-1626.
23. Anonymous. Army Individual Test Battery. Manual of Directions and Scoring. War Department, Adjutant Gernera's Office: Washington, DC, USA, 1944.
24. Beck A. Depression Inventory: Manual. Psychological Corporation: San Antonio, TX, USA, 1987.
25. Delis D, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test: Adult Version. The Psychological Corporation: San Antonio, USA, 1987.
26. Hooper HE. Hooper Visual Organization Test (VOT). Western Psychological Services: Los Angeles, CA, USA, 1983.
27. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Lea & Febiger: Boston, MA, USA, 1978.
28. Smith A. Symbol Digit Modalities Test (SDMT) Manual (revised). Western Psychological Services: Los Angeles, CA, USA, 1982.
29. Ko JH, Feigin A, Mattis PJ, Tang CC, Ma Y, Dhawan V et al. Network modulation following sham surgery in Parkinson's disease. J Clin Invest 2014; 124: 3656-3666.
30. Habeck C, Stern Y. Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease. Cell Biochem Biophys 2010; 58: 53-67.
31. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. Thieme: New York, NY, USA, 1988.
32. Schmahmann JD, Doyon J, Toga AW, Petrides M, Evans AC. MRI Atlas of the Human Cerebellum. Academic Press: San Diego, CA, USA, 2000.
33. Bohnen NI, Frey KA. Parkinson Dementia: PET findings. In: Dierckx RA, Otte A, de Vries EFJ, van Waarde A, Leenders KL (eds). PET and SPECT in Neurology. Springer-Verlag: Berlin Heidelberg, Germany, 2014, pp 359.
34. Peng S, Ma Y, Spetsieris PG, Mattis P, Feigin A, Dhawan V et al. Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners. Hum Brain Mapp 2014; 35: 1801-1814.
35. Cohen OS, Vakil E, Tanne D, Molshatzki N, Nitsan Z, Hassin-Baer S. The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease. J Geriatr Psychiatry Neurol 2012; 25: 71-77.
36. Alvarez JA, Emory E. Executive function and the frontal lobes: a metaanalytic review. Neuropsychol Rev 2006; 16: 17-42.
37. Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA et al. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med 2011; 52: 848-855.
38. Pappata S, Santangelo G, Aarsland D, Vicidomini C, Longo K, Bronnick K et al. Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology 2011; 77: 1357-1362.
39. Garcia-Garcia D, Clavero P, Gasca Salas C, Lamet I, Arbizu J, Gonzalez-Redondo R et al. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. Eur J Nucl Med Mol Imaging 2012; 39: 1767-1777.
40. Carbon M, Ma Y, Barnes A, Dhawan V, Chaly T, Ghilardi MF et al. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage 2004; 21: 1497-1507.
41. Niethammer M, Tang CC, Ma Y, Mattis PJ, Ko JH, Dhawan V et al. Parkinson's disease cognitive network correlates with caudate dopamine. Neuroimage 2013; 78: 204-209.
42. Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 2005; 65: 1716-1722.
43. Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. Behav Brain Res 2011; 221: 564-573.
44. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009; 132: 2958-2969.